pLentiCRISPR-mCherry Citations (4)
Originally described in: Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL.McComb S, Aguade-Gorgorio J, Harder L, Marovca B, Cario G, Eckert C, Schrappe M, Stanulla M, von Stackelberg A, Bourquin JP, Bornhauser BC Sci Transl Med. 2016 May 18;8(339):339ra70. doi: 10.1126/scitranslmed.aad2986. PubMed Journal
Articles Citing pLentiCRISPR-mCherry
| Articles |
|---|
| BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer. Shahbandi A, Rao SG, Anderson AY, Frey WD, Olayiwola JO, Ungerleider NA, Jackson JG. Cell Death Differ. 2020 May 26. pii: 10.1038/s41418-020-0564-6. doi: 10.1038/s41418-020-0564-6. PubMed |
| Efficient Generation of Multi-gene Knockout Cell Lines and Patient-derived Xenografts Using Multi-colored Lenti-CRISPR-Cas9. Behrmann L, McComb S, Aguade-Gorgorio J, Huang Y, Hermann M, Pelczar P, Aguzzi A, Bourquin JP, Bornhauser BC. Bio Protoc. 2017 Apr 5;7(7):e2222. doi: 10.21769/BioProtoc.2222. eCollection 2017 Apr 5. PubMed |
| Phosphoinositide species and filamentous actin formation mediate engulfment by senescent tumor cells. Frey WD, Anderson AY, Lee H, Nguyen JB, Cowles EL, Lu H, Jackson JG. PLoS Biol. 2022 Oct 24;20(10):e3001858. doi: 10.1371/journal.pbio.3001858. eCollection 2022 Oct. PubMed |
CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models.
Timpanaro A, Piccand C, Dzhumashev D, Anton-Joseph S, Robbi A, Moser J, Rossler J, Bernasconi M.
J Exp Clin Cancer Res. 2023 Nov 4;42(1):293. doi: 10.1186/s13046-023-02838-3.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.